Library / Mod GRF 1-29
Little direct research
Mod GRF 1-29
Short-acting GHRH analogue · Growth hormone · CJC-1295 without DAC
What it is
A modified, more stable version of sermorelin. It acts for a short time, triggering a brief pulse of growth hormone.
What research covers
There is very little published research on this exact compound. Most of what is said about it is borrowed from studies of sermorelin and of CJC-1295 with DAC.
Reported side effects
- Flushing or tingling after injection
- Injection-site reactions
- Fluid retention
- Higher blood sugar
Not suitable for, or talk to a doctor first
- Active cancer
- Pregnancy
- Diabetes without medical supervision
Good to know
- Often sold under the CJC-1295 name. Check the label for "no DAC" or "Mod GRF".
Legal status
| Australia | Not an approved medicine in Australia. Peptides like this are generally prescription-only (Schedule 4) and need a prescription to import. Check current rules with the TGA. |
|---|---|
| United States | Not FDA-approved. |
| Sport | Prohibited by the World Anti-Doping Agency (WADA) at all times. |
Rules change. Check with the TGA (Australia), your local regulator, or WADA for sport.
General information, not advice. Talk to a qualified healthcare professional before starting, changing or stopping anything.